9:38 AM
 | 
May 09, 2018
 |  BC Extra  |  Financial News

Chinese immuno-oncology play CStone raises $260M

CStone Pharmaceuticals Co. Ltd. (Suzhou, China) raised $260 million in a series B round led by new investor GIC Private. CStone said the round is the largest series B ever for a Chinese biopharma.

New investors in the round included Sequoia China, Yunfeng Capital, 6 Dimensions Capital, CITIC PE, Taikang Insurance Group,...

Read the full 237 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >